Cargando…
Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study
Hepatitis C (HCV) infection elimination in low- and middle-income countries requires decentralised HCV services to increase testing and linkage to care. The CT2 Study investigated patients’ views of access to and acceptance of two community-based HCV care models in Myanmar using a mixed-methods appr...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275420/ https://www.ncbi.nlm.nih.gov/pubmed/37327249 http://dx.doi.org/10.1371/journal.pgph.0000902 |
_version_ | 1785059869000204288 |
---|---|
author | Yee, Win Lei Bowring, Anna Draper, Bridget O’Keefe, Daniel Htay, Hla Myint, Kyi Thar Aung, Hnin Wai Phyo Win, Yu Yu Sein, Yi Yi Mary, Mary Lin, Aung Pedrana, Alisa Hellard, Margaret |
author_facet | Yee, Win Lei Bowring, Anna Draper, Bridget O’Keefe, Daniel Htay, Hla Myint, Kyi Thar Aung, Hnin Wai Phyo Win, Yu Yu Sein, Yi Yi Mary, Mary Lin, Aung Pedrana, Alisa Hellard, Margaret |
author_sort | Yee, Win Lei |
collection | PubMed |
description | Hepatitis C (HCV) infection elimination in low- and middle-income countries requires decentralised HCV services to increase testing and linkage to care. The CT2 Study investigated patients’ views of access to and acceptance of two community-based HCV care models in Myanmar using a mixed-methods approach. Point-of-care HCV testing and general practitioner-initiated HCV treatment were provided at two community clinics in Yangon, Myanmar–the Burnet Institute’s (BI) clinic focused on people who inject drugs (PWID), and the Myanmar Liver Foundation’s (MLF) clinic focused on people with liver-related diseases. Study staff administered quantitative questionnaires to 633 participants receiving anti-HCV antibody testing. Purposive sampling was used to recruit 29 participants receiving direct-acting antiviral treatment for qualitative interviews. Among participants completing quantitative questionnaires, almost all reported the clinic location was convenient (447/463, 97%), waiting time was acceptable (455/463, 98%), and HCV antibody and RNA testing methods were acceptable (617/632, 98% and 592/605, 97% respectively). Nearly all participants were satisfied with their clinic’s services (444/463, 96%) and preferred same-day test results (589/632, 93%). BI clinic participants were more confident that they understood HCV antibody and RNA results; MLF clinic participants were more comfortable disclosing their risk behaviour to staff and had slightly higher satisfaction with the overall care, privacy and secure storage of their information. In qualitative interviews, participants reported that flexible appointment scheduling, short wait times and rapid return of results increased the clinic’s accessibility. The simplified point-of-care testing and treatment procedures and supportive healthcare providers contributed to participants’ acceptance of the HCV care model. This decentralised community-based HCV testing and treatment model was highly accessible and acceptable to CT2 participants. Prioritizing patient-centred care, rapid provision of results, flexible appointments and convenient clinic locations can promote accessible and acceptable services which may in turn help accelerate progress in reaching HCV elimination targets. |
format | Online Article Text |
id | pubmed-10275420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102754202023-06-17 Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study Yee, Win Lei Bowring, Anna Draper, Bridget O’Keefe, Daniel Htay, Hla Myint, Kyi Thar Aung, Hnin Wai Phyo Win, Yu Yu Sein, Yi Yi Mary, Mary Lin, Aung Pedrana, Alisa Hellard, Margaret PLOS Glob Public Health Research Article Hepatitis C (HCV) infection elimination in low- and middle-income countries requires decentralised HCV services to increase testing and linkage to care. The CT2 Study investigated patients’ views of access to and acceptance of two community-based HCV care models in Myanmar using a mixed-methods approach. Point-of-care HCV testing and general practitioner-initiated HCV treatment were provided at two community clinics in Yangon, Myanmar–the Burnet Institute’s (BI) clinic focused on people who inject drugs (PWID), and the Myanmar Liver Foundation’s (MLF) clinic focused on people with liver-related diseases. Study staff administered quantitative questionnaires to 633 participants receiving anti-HCV antibody testing. Purposive sampling was used to recruit 29 participants receiving direct-acting antiviral treatment for qualitative interviews. Among participants completing quantitative questionnaires, almost all reported the clinic location was convenient (447/463, 97%), waiting time was acceptable (455/463, 98%), and HCV antibody and RNA testing methods were acceptable (617/632, 98% and 592/605, 97% respectively). Nearly all participants were satisfied with their clinic’s services (444/463, 96%) and preferred same-day test results (589/632, 93%). BI clinic participants were more confident that they understood HCV antibody and RNA results; MLF clinic participants were more comfortable disclosing their risk behaviour to staff and had slightly higher satisfaction with the overall care, privacy and secure storage of their information. In qualitative interviews, participants reported that flexible appointment scheduling, short wait times and rapid return of results increased the clinic’s accessibility. The simplified point-of-care testing and treatment procedures and supportive healthcare providers contributed to participants’ acceptance of the HCV care model. This decentralised community-based HCV testing and treatment model was highly accessible and acceptable to CT2 participants. Prioritizing patient-centred care, rapid provision of results, flexible appointments and convenient clinic locations can promote accessible and acceptable services which may in turn help accelerate progress in reaching HCV elimination targets. Public Library of Science 2023-06-16 /pmc/articles/PMC10275420/ /pubmed/37327249 http://dx.doi.org/10.1371/journal.pgph.0000902 Text en © 2023 Yee et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yee, Win Lei Bowring, Anna Draper, Bridget O’Keefe, Daniel Htay, Hla Myint, Kyi Thar Aung, Hnin Wai Phyo Win, Yu Yu Sein, Yi Yi Mary, Mary Lin, Aung Pedrana, Alisa Hellard, Margaret Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study |
title | Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study |
title_full | Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study |
title_fullStr | Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study |
title_full_unstemmed | Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study |
title_short | Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study |
title_sort | patients’ access to and acceptance of community-based hepatitis c testing and treatment in myanmar: a mixed-method study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275420/ https://www.ncbi.nlm.nih.gov/pubmed/37327249 http://dx.doi.org/10.1371/journal.pgph.0000902 |
work_keys_str_mv | AT yeewinlei patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT bowringanna patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT draperbridget patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT okeefedaniel patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT htayhla patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT myintkyithar patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT aunghninwaiphyo patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT winyuyu patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT seinyiyi patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT marymary patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT linaung patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT pedranaalisa patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy AT hellardmargaret patientsaccesstoandacceptanceofcommunitybasedhepatitisctestingandtreatmentinmyanmaramixedmethodstudy |